These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 33146895)
1. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies. Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Cytotoxicity of New Coumarin-1,2,3-triazole Derivatives: Evaluation of Anticancer Activity and Molecular Docking Studies. Premsagar Miriyala V; Raj Thommandru P; Kashanna J; Govinda V; Ravi G; Kishore R Chem Biodivers; 2023 Jul; 20(7):e202300269. PubMed ID: 37204157 [TBL] [Abstract][Full Text] [Related]
3. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged β-Lactam Triazole Hybrid. Dhawan S; Awolade P; Kisten P; Cele N; Pillay AS; Saha S; Kaur M; Jonnalagadda SB; Singh P Chem Biodivers; 2020 Jan; 17(1):e1900462. PubMed ID: 31788939 [TBL] [Abstract][Full Text] [Related]
5. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach. Mamatha SV; Belagali SL; Bhat M; Kumbar VM Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents. An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents. Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids. Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents. Liu CF; Shen QK; Li JJ; Tian YS; Quan Z J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1111-1119. PubMed ID: 28791908 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent. Murugavel S; Ravikumar C; Jaabil G; Alagusundaram P Comput Biol Chem; 2019 Apr; 79():73-82. PubMed ID: 30731361 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells. Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents. Goud NS; Pooladanda V; Mahammad GS; Jakkula P; Gatreddi S; Qureshi IA; Alvala R; Godugu C; Alvala M Chem Biol Drug Des; 2019 Sep; 94(5):1919-1929. PubMed ID: 31169963 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Paul K; Bindal S; Luxami V Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents. Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Coumarin-Triazole Hybrid Molecules as Potential Antitumor and Pancreatic Lipase Agents. Kahveci B; Yılmaz F; Menteşe E; Ülker S Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28543820 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents. Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398 [TBL] [Abstract][Full Text] [Related]
19. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies. Kamath PR; Sunil D; Ajees AA; Pai KS; Das S Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and in vitro anticancer evaluation of novel 1,2,4-triazolin-3-one derivatives. Kattimani PP; Kamble RR; Kariduraganavar MY; Dorababu A; Hunnur RK Eur J Med Chem; 2013 Apr; 62():232-40. PubMed ID: 23353755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]